Scholar Rock Holding (SRRK) Other Working Capital Changes (2018 - 2026)
Scholar Rock Holding's (SRRK) quarterly Other Working Capital Changes came in at -$1.4 million in Q1 2026, up 8.56% year-on-year from -$1.3 million in Q1 2025, and down 14.61% quarter-over-quarter from -$1.3 million in Q4 2025.
Scholar Rock Holding (SRRK) Other Working Capital Changes (2018 - 2026) Analysis & Trends
Scholar Rock Holding's Other Working Capital Changes history runs 9 years deep, the most recent figure standing at -$1.4 million for Q1 2026.
- On a quarterly basis, Other Working Capital Changes rose 8.56% year-over-year to -$1.4 million in Q1 2026; TTM through Mar 2026 was -$5.6 million, a 7.25% increase from a year earlier, with the FY2025 full-year figure at -$5.8 million, up 7.93% from the prior year.
- Other Working Capital Changes eased to -$1.4 million in Q1 2026 per SRRK's latest filing, from -$1.3 million in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $7.0 million in Q1 2025 and bottomed at -$4.5 million in Q3 2022.
- The 5-year median for Other Working Capital Changes is $36000.0 (2024), against an average of $429058.8.
- Biggest YoY gain for Other Working Capital Changes was 1626.02% in 2022; the steepest drop was 14984.75% in 2022.
- Year by year, Other Working Capital Changes stood at $219000.0 in 2022, then tumbled by 136.53% to -$80000.0 in 2023, then tumbled by 1808.75% to -$1.5 million in 2024, then advanced by 17.55% to -$1.3 million in 2025, then dropped by 14.61% to -$1.4 million in 2026.
- Per Business Quant, the three latest SRRK Other Working Capital Changes figures stand at -$1.4 million (Q1 2026), -$1.3 million (Q4 2025), and -$1.3 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Scholar Rock Holding | 6.30 Bn | 6.30 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.44 Mn |
| Mar 31, 2026 | -1.44 Mn |
| Mar 31, 2026 | -1.44 Mn |
| Dec 31, 2025 | -1.26 Mn |
| Dec 31, 2025 | -1.26 Mn |
| Dec 31, 2025 | -1.26 Mn |
| Sep 30, 2025 | -1.31 Mn |
| Sep 30, 2025 | -1.31 Mn |
| Sep 30, 2025 | -1.31 Mn |
| Jun 30, 2025 | -1.63 Mn |
| Jun 30, 2025 | -1.63 Mn |
| Jun 30, 2025 | -1.63 Mn |
| Mar 31, 2025 | -1.58 Mn |
| Mar 31, 2025 | -1.58 Mn |
| Mar 31, 2025 | -1.58 Mn |
| Dec 31, 2024 | -1.53 Mn |
| Dec 31, 2024 | -1.53 Mn |
| Dec 31, 2024 | -1.53 Mn |
| Sep 30, 2024 | -1.46 Mn |
| Sep 30, 2024 | -1.46 Mn |